Equity grants to MapLight Therapeutics (MPLT) director Troy Cox
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
MapLight Therapeutics director Troy Cox received new equity awards as part of non-employee director compensation. He was granted 7,864 restricted stock units, each representing one share of voting common stock. These RSUs vest in three equal annual installments beginning on June 23, 2027, contingent on his continued service.
He was also granted a stock option covering 29,804 shares of voting common stock at an exercise price of $28.64 per share, vesting on the same three-year schedule starting June 23, 2027. After these grants, his reported direct holdings include 7,864 shares from RSUs and 29,804 underlying option shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Cox Troy
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 29,804 | $0.00 | -- |
| Grant/Award | Voting Common Stock | 7,864 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 29,804 shares (Direct, null);
Voting Common Stock — 7,864 shares (Direct, null)
Footnotes (1)
- Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest in three equal annual installments beginning on June 23, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest in three equal annual installments beginning on June 23, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.
Key Figures
RSUs granted: 7,864 units
Options granted: 29,804 shares
Option exercise price: $28.64 per share
+4 more
7 metrics
RSUs granted
7,864 units
Restricted stock units granted June 23, 2026
Options granted
29,804 shares
Stock option grant June 23, 2026
Option exercise price
$28.64 per share
Stock option on Voting Common Stock
RSU vesting start
June 23, 2027
First of three equal annual installments
Option vesting end
Three annual installments
Beginning June 23, 2027, subject to Continuous Service
Shares held after RSU grant
7,864 shares
Voting Common Stock following RSU award
Underlying option shares after grant
29,804 shares
Voting Common Stock underlying option after grant
Key Terms
restricted stock units, 2025 Equity Incentive Plan, Continuous Service, non-employee director compensation policy, +1 more
5 terms
restricted stock units financial
"Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2025 Equity Incentive Plan financial
"granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan")"
Continuous Service financial
"subject to the Continuous Service (as defined in the Plan) of the Reporting Person"
non-employee director compensation policy financial
"This grant was made pursuant to the Issuer's non-employee director compensation policy"
stock option financial
"Represents a stock option granted pursuant to the Plan"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
FAQ
What insider transaction did MapLight Therapeutics (MPLT) report for Troy Cox?
MapLight Therapeutics reported that director Troy Cox received equity compensation. He was granted 7,864 restricted stock units and a stock option for 29,804 shares, both under the 2025 Equity Incentive Plan, rather than buying shares in the open market.
How many RSUs did Troy Cox receive from MapLight Therapeutics (MPLT)?
Troy Cox received 7,864 restricted stock units from MapLight Therapeutics. Each RSU represents a contingent right to receive one share of voting common stock, subject to vesting conditions tied to his continued service on the board over three years.
What are the terms of Troy Cox’s stock option grant at MapLight Therapeutics (MPLT)?
Troy Cox received a stock option covering 29,804 shares of voting common stock at an exercise price of $28.64 per share. The option vests in three equal annual installments starting June 23, 2027, subject to his continued service as defined in the company’s plan.
When do Troy Cox’s RSUs and options from MapLight Therapeutics (MPLT) vest?
Both the RSUs and stock options granted to Troy Cox vest in three equal annual installments beginning June 23, 2027. Vesting requires that he maintain Continuous Service, as defined in MapLight Therapeutics’ 2025 Equity Incentive Plan, on each applicable vesting date.